EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Minimally Invasive Injectable Gel for Local Immunotherapy of Liver and Gastric Cancer

Xinghui Si, Guofeng Ji, Sheng Ma, Zichao Huang, Taiyuan Liu, Zhiyuan Shi, Yu Zhang, Jia Li, Wantong Song iD, Xuesi Chen

Advanced Science · 2024-10 · 11 (38)

DOI: 10.1002/advs.202405935 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.08.2024. Verfasst von Xinghui Si und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Immunotherapy, Liver Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Bureau of International Cooperation Chinese Academy of Sciences, Jilin Province Development and Reform Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Local immunotherapy represents a promising solution for preventing tumor recurrence and metastasis post tumor surgical resection by eliminating residue tumor cells as well as eliciting tumor‐specific immune responses. Minimally invasive surgery has become a mainstream surgical method worldwide due to its advantages of aesthetics and rapid postoperative recovery. Unfortunately, the currently reported local immunotherapy strategies are mostly designed to be used after open laparotomy, which go against the current surgical philosophy of minimally invasive therapy and is not suitable for clinical translation. Aiming at this problem, a minimally invasive injectable gel (MIGel) is herein reported loaded with immunotherapeutic agents for gastric and liver cancer postoperative treatment. The MIGel is formed by crosslinking between oxidized dextran (ODEX) and 4‐arm polyethylene glycol hydroxylamine (4‐arm PEG‐ONH 2 ) through oxime bonds, which can be injected through a clinic‐used minimally invasive drainage tube and adhered tightly to the tissue. The loaded oxaliplatin (OxP) and resiquimod (R848) can be released constantly over two weeks and resulted in over 75% cure rate in orthotopic mouse gastric and liver cancer model. Collectively, a concept of minimally invasive local immunotherapy is proposed and MIGel is designed for local intraperitoneal cancer immunotherapy through minimally invasive surgery, with good clinical translation potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsImmunotherapyLiver NeoplasmsAnimalsMiceGelsDisease Models, AnimalMinimally Invasive Surgical ProceduresHumansOxaliplatin

Stichwörter der Autor:innen

cancer immunotherapygastric cancerhydrogelsliver cancerminimally invasive injection

Substanzen

GelsOxaliplatin

Autor:innen und Institutionen

  • Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, China.
  • Jilin Biomedical Polymers Engineering Laboratory, Changchun, 130022, China.
  • Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, China.
  • The Second Hospital of Jilin University, Changchun, 130000, China.

ORCID-Profile: Wantong Song

Förderung

  • National Natural Science Foundation of China
  • Bureau of International Cooperation Chinese Academy of Sciences
  • Jilin Province Development and Reform Commission
  • Jilin Provincial International Cooperation Key Laboratory of Biomedical Polymers
  • Jilin Province Science and Technology Development Plan
  • Changchun Science and Technology Development Plan
  • Youth Innovation Promotion Association of Chinese Academy of Sciences
  • Youth Innovation Promotion Association of the Chinese Academy of Sciences

Zitieren

APA

Si, X., Ji, G., Ma, S., Huang, Z., Liu, T., Shi, Z., Zhang, Y., Li, J., Song, W., & Chen, X. (2024). Minimally Invasive Injectable Gel for Local Immunotherapy of Liver and Gastric Cancer. Advanced Science, 11(38). https://doi.org/10.1002/advs.202405935

Vancouver

Si X, Ji G, Ma S, Huang Z, Liu T, Shi Z, et al. Minimally Invasive Injectable Gel for Local Immunotherapy of Liver and Gastric Cancer. Advanced Science. 2024;11(38). doi:10.1002/advs.202405935

BibTeX
@article{Si2024,
  author = {Si, Xinghui and Ji, Guofeng and Ma, Sheng and Huang, Zichao and Liu, Taiyuan and Shi, Zhiyuan and Zhang, Yu and Li, Jia and Song, Wantong and Chen, Xuesi},
  title = {Minimally Invasive Injectable Gel for Local Immunotherapy of Liver and Gastric Cancer},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {38},
  doi = {10.1002/advs.202405935}
}
Kostenlos starten →